Preclinical validation of electrochemotherapy as an effective treatment for brain tumors.

Electrochemotherapy represents a strategy to enhance chemotherapeutic drug uptake by delivering electrical pulses which exceed the dielectric strength of the cell membrane, causing transient formation of structures that enhance permeabilization. Here we show that brain tumors in a rat model can be eliminated by electrochemotherapy with a novel electrode device developed for use in the brain. By using this method, the cytotoxicity of bleomycin can be augmented more than 300-fold because of increased permeabilization and more direct passage of drug to the cytosol, enabling highly efficient local tumor treatment. Bleomycin was injected intracranially into male rats inoculated with rat glia-derived tumor cells 2 weeks before the application of the electrical field (32 pulses, 100 V, 0.1 ms, and 1 Hz). In this model, where presence of tumor was confirmed by magnetic resonance imaging (MRI) before treatment, we found that 9 of 13 rats (69%) receiving electrochemotherapy displayed a complete elimination of tumor, in contrast to control rats treated with bleomycin only, pulses only, or untreated where tumor progression occurred in each case. Necrosis induced by electrochemotherapy was restricted to the treated area, which MRI and histology showed to contain a fluid-filled cavity. In a long-range survival study, treatment side effects seemed to be minimal, with normal rat behavior observed after electrochemotherapy. Our findings suggest that electrochemotherapy may offer a safe and effective new tool to treat primary brain tumors and brain metastases.

[1]  T. L. Ellis,et al.  Non-Thermal Irreversible Electroporation (N-TIRE) and Adjuvant Fractionated Radiotherapeutic Multimodal Therapy for Intracranial Malignant Glioma in a Canine Patient , 2011, Technology in cancer research & treatment.

[2]  Rafael V. Davalos,et al.  Intracranial Nonthermal Irreversible Electroporation: In Vivo Analysis , 2010, The Journal of Membrane Biology.

[3]  L. Mir,et al.  Antitumor electrochemotherapy: New advances in the clinical protocol , 1996, Cancer.

[4]  Richard Heller,et al.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Julie Gehl,et al.  Clinical aspects of electroporation , 2011 .

[6]  Helle K. Iversen,et al.  Diffusion-Weighted MRI for Verification of Electroporation-Based Treatments , 2011, The Journal of Membrane Biology.

[7]  Julie Gehl,et al.  Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. , 2003, Cancer treatment reviews.

[8]  J. Gehl,et al.  Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. , 2003, Acta physiologica Scandinavica.

[9]  Thomas L Ellis,et al.  Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation. , 2011, Journal of neurosurgery.

[10]  L. Mir,et al.  Cell Electropermeabilization and Cellular Uptake of Small Molecules: The Electrochemotherapy Concept , 2011 .

[11]  Julie Gehl,et al.  Bleomycin treatment of brain tumors: an evaluation. , 2009, Anti-cancer drugs.

[12]  M. Jaroszeski,et al.  Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin , 1998, Cancer.

[13]  D. W. Weiss,et al.  Immunology of Spontaneous Mammary Carcinomas in Mice , 1966 .

[14]  M. Jaroszeski,et al.  Electrochemotherapy: an emerging drug delivery method for the treatment of cancer. , 1997, Advanced drug delivery reviews.

[15]  D Miklavcic,et al.  The importance of electric field distribution for effective in vivo electroporation of tissues. , 1998, Biophysical journal.

[16]  L. Salford,et al.  Immunization with mutagen-treated (tum−) cells causes rejection of nonimmunogenic rat glioma isografts , 2005, Cancer Immunology, Immunotherapy.

[17]  Julie Gehl,et al.  Electroporation for drug and gene delivery in the clinic: doctors go electric. , 2008, Methods in molecular biology.

[18]  L. Mir,et al.  Electrochemotherapy, a new antitumor treatment. First clinical phase I‐II trial , 1993, Cancer.

[19]  Richard Heller,et al.  Electroporation gene therapy preclinical and clinical trials for melanoma. , 2010, Current gene therapy.

[20]  P. Fourie,et al.  Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations , 2004, Pediatric Surgery International.

[21]  M. Rols,et al.  Direct visualization at the single-cell level of electrically mediated gene delivery , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Damijan Miklavcic,et al.  Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy , 2010, Biomedical engineering online.

[23]  L. Mir,et al.  In vivo evolution of tumour cells after the generation of double-strand DNA breaks , 2003, British Journal of Cancer.

[24]  G. Tozer,et al.  Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy , 2001, British Journal of Cancer.

[25]  M. Čemažar,et al.  Vascular-Disrupting Action of Electrochemotherapy: Mode of Action and Therapeutic Implications , 2011 .

[26]  P. Siesjö,et al.  CD133+ and nestin+ tumor‐initiating cells dominate in N29 and N32 experimental gliomas , 2009, International journal of cancer.

[27]  W. Hall,et al.  Brain metastases: Histology, multiplicity, surgery, and survival , 1996 .

[28]  L. Einhorn.  Curing metastatic testicular cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Gehl,et al.  Duration and level of transgene expression after gene electrotransfer to skin in mice , 2010, Gene Therapy.

[30]  P Raskmark,et al.  In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. , 1999, Biochimica et biophysica acta.

[31]  Damijan Miklavcic,et al.  Robustness of Treatment Planning for Electrochemotherapy of Deep-Seated Tumors , 2010, The Journal of Membrane Biology.

[32]  J. Gehl,et al.  Electrochemotherapy of Small Tumors; The Experience from the ESOPE (European Standard Operating Procedures for Electrochemotherapy) Group , 2011 .

[33]  J. Gehl,et al.  Electrochemotherapy for Larger Malignant Tumors , 2011 .

[34]  卡伦·朱莉·格尔,et al.  Electrode introducer device , 2007 .

[35]  M. Bureau,et al.  High-efficiency gene transfer into skeletal muscle mediated by electric pulses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. Mir,et al.  Therapeutic perspectives of in vivo cell electropermeabilization. , 2001, Bioelectrochemistry.

[37]  J. Gehl,et al.  Electric pulse-mediated gene delivery to various animal tissues. , 2005, Advances in genetics.

[38]  M J Jaroszeski,et al.  Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy , 1996, Cancer.

[39]  L. Mir,et al.  The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway , 2001, British Journal of Cancer.

[40]  Faisal Mahmood,et al.  Optimizing clinical performance and geometrical robustness of a new electrode device for intracranial tumor electroporation. , 2011, Bioelectrochemistry.

[41]  J. Gehl,et al.  Management of cutaneous metastases using electrochemotherapy , 2011, Acta oncologica.

[42]  Rafael V. Davalos,et al.  Successful treatment of a large soft tissue sarcoma with irreversible electroporation. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  K. Smedby,et al.  Brain metastases admissions in Sweden between 1987 and 2006 , 2009, British Journal of Cancer.

[44]  M Fini,et al.  Ablation of bone cells by electroporation. , 2010, The Journal of bone and joint surgery. British volume.

[45]  Damijan Miklavčič,et al.  Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study , 2006 .

[46]  Electroporation- and Mechanical Ventilation-Mediated Gene Transfer to the Lung , 2010, Gene Therapy.

[47]  A Brun,et al.  A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. , 1993, Biochemical and biophysical research communications.

[48]  M. Jaroszeski,et al.  Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. , 1997, Journal of the American Academy of Dermatology.

[49]  D. W. Weiss,et al.  IMMUNOLOGY OF SPONTANEOUS MAMMARY CARCINOMAS IN MICE. II. RESISTANCE TO A RAPIDLY AND A SLOWLY DEVELOPING TUMOR. , 1965, Cancer research.

[50]  J. Gehl,et al.  Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation , 2007, Gene Therapy.